Thus, alterations in the LRP6 gene might affect Wnt/β-catenin signaling and lead to several human diseases including osteoporosis, Alzheimer's disease, coronary artery disease, and metabolic disease (20, 26–31). The gene discussed is LRP6; the disease is Alzheimer disease.